REPORT HIGHLIGHT
Softgel Capsules Market size was valued at USD 8,070.2 Million in 2022, expanding at a CAGR of 8.3% from 2023 to 2030.
Softgel capsules have numerous advantages over traditional capsules, including ease of ingestion, masking of odor and taste, enhanced absorption, higher bioavailability, and improved stability in various atmospheric conditions. With advancements in manufacturing technology and the incorporation of new materials, traditional capsules have gained additional features such as controlled drug release, tamper-evident packaging, and a wider range of formulation options that result in reduced degradation in low stomach pH, improved appearance, and longer shelf life.
In recent years, softgel producers have focused on developing gelatin-free capsules using plant-based polymers like starch, HPMC, and pullulan-type gums to cater to the needs of vegetarians. The benefits of non-gelatin capsules include technical advantages for producers and suppliers, as well as reduced waste from animal sources. Aenova's introduction of vegetable capsules boosted their sales revenue by a substantial margin. Eurocaps is developing a chewable softgel capsule with improved flavor masking capabilities, while market leaders such as Catalent and Roquette are creating vegan capsules to capture a share of the growing vegan population.
Softgel Capsules Market- Key Insights:
- As per the analysis shared by our research analyst, the global Softgel Capsules market is estimated to grow annually at a CAGR of around 8.3% over the forecast period (2023-2030)
- The nutraceutical industry is a key driver of the softgel capsules market, with increasing demand for dietary supplements, vitamins, and omega-3 fatty acids. Softgel capsules provide an ideal delivery system for these nutraceutical products, ensuring accurate dosing, enhanced stability, and improved consumer compliance.
- Gelatin-based softgel capsules hold a significant market share due to their widespread use in pharmaceutical and nutraceutical industries. The gelatin capsules offer advantages such as easy swallowing, better bioavailability, and compatibility with a wide range of formulations.
- On the basis of region, North America was the leading revenue generator in 2022
Regional Insights:
- The major portion of the Softgel market is in North America. The presence of pharma leaders in the area and the existence of health-conscious customers are other contributing variables that account for the biggest market share. The market with the fastest growth, though, is APAC. High growth is attributed to a number of factors, including the profusion of generic drug producers in China and India, rising demand for affordable treatments, booming economic conditions, and expansion of contract manufacturing businesses in the area. The expansion of the European market is projected to be aided by the rise in spending on customized medicine and the implementation of high-tech softgel production methods.
Recent Developments:
- In August 2021, Catalent, Inc. acquired Bettera Holdings, LLC, and a prominent manufacturer in the nutritional supplements market. This has significantly strengthened company's softgel product portfolio and broadened manufacturing capabilities.
- In October 2021, Aenova with AlaskOmega AG, and Algarithm developed and manufacturing VegaGels that are filled with omega-3 DHA fatty acids from microalgae. These capsules are vegan and chewable in nature.
Key features of the study:
- This proposed research study on Softgel Capsules market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Softgel Capsules market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Softgel Capsules market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Softgel Capsules market
- Impact of COVID-19 on Softgel Capsules market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Softgel Capsules market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Softgel Capsules market, we have also included competitive landscape and key innovator analysis for the Softgel Capsules market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Softgel Capsules market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Softgel Capsules market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SOFTGEL CAPSULES MARKET KEY PLAYERS
- Aenova Group
- EuroCaps Ltd.
- Catalent, Inc.
- Capsugel (now Lonza Group Ltd.)
- Patheon (Thermo Fisher Scientific)
- Sirio Pharma Co., Ltd.
- NBTY, Inc. (Nature's Bounty Co.)
- Robinson Pharma, Inc.
- Softigel (Procaps S.A.)
- Nutrilo GmbH
GLOBAL SOFTGEL CAPSULES MARKET, BY PRODUCT TYPE
- Gelatin /Animal based
- Non-animal based
GLOBAL SOFTGEL CAPSULES MARKET, BY APPLICATION
- Antacid & Anti-flatulent Preparations
- Anti-anemic Preparations
- Anti-inflammatory Drugs
- Antibiotic & Antibacterial Drugs
- Cough & Cold Preparations
- Health Supplement
- Vitamin & Dietary Supplement
- Pregnancy
GLOBAL SOFTGEL CAPSULES MARKET, BY END USER
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organizations
GLOBAL SOFTGEL CAPSULES MARKET, BY REGION
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA